(A.K.A. Non-Original Rants)

–Co-opting good stuff from all over the ‘Net and maybe some original thoughts—ΜΟΛΩΝ ΛΑΒE

________________________________________________________________________________________________

Vaccine trial halted over failure to prevent infection

 Nope, it’s not what you think.  ETA:  the previous link is behind a firewall at the Epoch Times.  Here’s another one:  https://interestingengineering.com/health/janssen-discontinues-trial-hiv-vaccine

Companies have halted an advanced trial of an HIV vaccine because the shot was found to not prevent infection.

Results from the stage 3 trial led to the determination that the vaccine “was not effective in preventing HIV infection compared to placebo among study participants,” Johnson & Johnson and its partners said in a statement.

This study has been going on since 2019.  It wasn’t fast-tracked with brand new, DNA changing technology.  A different study was discontinued in 2021 because it had an ‘efficacy’ of 25.2%.  As a note, this trial is NOT using mRNA.

 U.S. regulators generally consider 50 percent to be the bar for an effective vaccine, though they have allowed that standard to be bypassed by COVID-19 vaccines.

Of course they started mRNA versions for HIV based on “the success of safe and highly effective COVID-19 vaccines” according to Fauci, who authorized them before exiting stage left from the NAIAD.

Considering the fact that the covid shots are neither safe nor effective, I find it interesting that they would even bother with this new study for HIV.



  1. the vax is effective in causing heart failure.

    Like

  2. Avraham–True. So it does something. Not the thing it's supposed to, but something.

    Like

  3. Sigh… Here we go again.

    Like

  4. the vax is effective in causing heart failure.

    Like

  5. Avraham–True. So it does something. Not the thing it's supposed to, but something.

    Like

  6. Sigh… Here we go again.

    Like

Leave a Reply to Anonymous Cancel reply

Your email address will not be published. Required fields are marked *